MSA
This generated page lists source notes whose first nav_path entry is MSA. It is a coverage index, not a full synthesis page.
| source | nav path | headings |
|---|---|---|
| 20240722_184156 | MSA > aSyn in MSA > CSF aSyn in MSA | MRI in PD; MRS in PD; MSA; Animal models of MSA; aSyn in MSA; … |
| 20240722_184206 | MSA | Diagnosis of MSA – three levels; Uncertain Spans |
| 20240722_184210 | MSA > Dx of MSA > Imaging | Dx of MSA; Criteria for the Diagnosis of Probable MSA; Criteria for Possible MSA; Genetics; In vitro systems; … |
| 20240722_184216 | MSA > Outcome Measures > Unified MSA Rating Scale (UMSARS) | NfL in MSA, Outcome Measures, UMSARS, MSA-QoL Start; NfL Longitudinal Table (continued); NfL Cross-Sectional / Longitudinal CSF and Blood Comparison; Outcome Measures; Unified MSA Rating Scale (UMSARS); … |
| 20240722_184219 | MSA > Outcome Measures > Pathology | Outcome Measures; Multiple System Atrophy Health-Related Quality of Life (MSA-QoL); ICLEMSA (Items That Change Largely in Early-Stage Multiple System Atrophy); Table 4 — The eight items with the largest standardized response mean; Table 5 — The required sample size to detect treatment effects for each scale; … |
| 20240722_184223 | MSA > Pipeline MSA > Disease-modifying | Pipeline MSA; Disease-modifying; Verdiperstat – Phase 2: NCT02388295; Uncertain Spans |
| 20240722_184226 | MSA > Pipeline MSA > Disease-modifying | Uncertain Spans |
| 20240722_184233 | MSA > Pathology > TM in MSA > Mucolipidosis (ML) | Pathology — comparison across MSA subtypes; TM in MSA; Mucolipidosis (ML); Uncertain Spans |